Skip to content
Tuesday, July 14, 2026
  • Business
  • Education
  • Entertainment
  • Health
  • Lifestyle
  • National
  • Press Release
  • Technology
Just News Now

Just News Now

  • Business
  • Education
  • Entertainment
  • Health
  • Lifestyle
  • National
  • Press Release
  • Technology
You are Here
  • Home
  • Molnupiravir

Tag: Molnupiravir

National Press Release

Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India

July 21, 2021

Hyderabad (Telangana) [India], July 21: Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients

Covid-19, D Srinivasa Reddy, DCGI, Drugs Controller General of India, Interim Clinical Results, Molnupiravir, Optimus Pharma, Phase III Clinical Trials, SARS-CoV-2

Recent Posts

  • Automation Expo 2026 to Spotlight AI, Smart Manufacturing, and Industrial Innovation in Mumbai
  • Chandan Healthcare Limited Q1 FY27 Operational Update: Operating Income Up 35.64% YoY to ₹48.67 Cr; Pharmacy Up 13.69% YoY to ₹32.33 Cr
  • YAAP Digital Announces Leadership Transition; Appoints Raj Nayak as Chairman & Managing Director
  • BIRLA AIRCON Earns Bureau of Indian Standards Appreciation for Quality Excellence, Records Over 700% Growth
  • UniHealth Launches Comprehensive Eye Care and Ophthalmology Services at UMC Victoria Hospital, Uganda
  • Vivid Electromech Reports 36% YoY Revenue Growth in Q1 FY27; Order Pipeline Strong at Rs 210 Cr
  • Captain Polyplast Limited Strengthens Solar EPC Order Book with Rs 23.6 Cr MSEDCL Order for 1,000 Solar Pumps
  • Aalpha Launches DeliveryStack, Tackling Why Most On-Demand Delivery Startups Fail Before They Launch
  • BNI Surat to host 10th Business Conclave on July 18-19
  • Hamstech Launches MBA Programmes to Shape the Next Generation of Fashion and Interior Design Leaders

Mail us : [email protected]

All Rights Reserved 2023.
Proudly powered by WordPress | Theme: Recent News by Candid Themes.